Literature DB >> 29513615

Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History.

Hilary D Marston1, Catharine I Paules1, Anthony S Fauci1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29513615     DOI： 10.1056/NEJMp1802256

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

1.  A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.

Authors:  Nurgun Kose; Julie M Fox; Gopal Sapparapu; Robin Bombardi; Rashika N Tennekoon; A Dharshan de Silva; Sayda M Elbashir; Matthew A Theisen; Elisabeth Humphris-Narayanan; Giuseppe Ciaramella; Sunny Himansu; Michael S Diamond; James E Crowe
Journal:  Sci Immunol       Date:  2019-05-17

Review 2.  SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Authors:  Nina Kreuzberger; Caroline Hirsch; Khai Li Chai; Eve Tomlinson; Zahra Khosravi; Maria Popp; Miriam Neidhardt; Vanessa Piechotta; Susanne Salomon; Sarah J Valk; Ina Monsef; Christoph Schmaderer; Erica M Wood; Cynthia So-Osman; David J Roberts; Zoe McQuilten; Lise J Estcourt; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2021-09-02

Review 3.  SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.

Authors:  Caroline Hirsch; Yun Soo Park; Vanessa Piechotta; Khai Li Chai; Lise J Estcourt; Ina Monsef; Susanne Salomon; Erica M Wood; Cynthia So-Osman; Zoe McQuilten; Christoph D Spinner; Jakob J Malin; Miriam Stegemann; Nicole Skoetz; Nina Kreuzberger
Journal:  Cochrane Database Syst Rev       Date:  2022-06-17

4.  Antiviral Activity of a Llama-Derived Single-Domain Antibody against Enterovirus A71.

Authors:  Peng-Nien Huang; Hsiang-Ching Wang; Hui-Chen Hung; Sung-Nien Tseng; Teng-Yuan Chang; Min-Yuan Chou; Yu-Jen Chen; Yun-Ming Wang; Shin-Ru Shih; John Tsu-An Hsu
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

5.  Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.

Authors:  Raffael Nachbagauer; David Shore; Hua Yang; Scott K Johnson; Jon D Gabbard; S Mark Tompkins; Jens Wrammert; Patrick C Wilson; James Stevens; Rafi Ahmed; Florian Krammer; Ali H Ellebedy
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation.

Authors:  Jean M Lodge; Kevin L Schauer; Dain R Brademan; Nicholas M Riley; Evgenia Shishkova; Michael S Westphall; Joshua J Coon
Journal:  Anal Chem       Date:  2020-07-16       Impact factor: 6.986

7.  Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection.

Authors:  Florian Wrensch; Gaëtan Ligat; Laura Heydmann; Catherine Schuster; Mirjam B Zeisel; Patrick Pessaux; François Habersetzer; Barnabas J King; Alexander W Tarr; Jonathan K Ball; Michael Winkler; Stefan Pöhlmann; Zhen-Yong Keck; Steven K H Foung; Thomas F Baumert
Journal:  Hepatology       Date:  2019-06-21       Impact factor: 17.298

8.  A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.

Authors:  Wafaa B Alsoussi; Jackson S Turner; James B Case; Haiyan Zhao; Aaron J Schmitz; Julian Q Zhou; Rita E Chen; Tingting Lei; Amena A Rizk; Katherine M McIntire; Emma S Winkler; Julie M Fox; Natasha M Kafai; Larissa B Thackray; Ahmed O Hassan; Fatima Amanat; Florian Krammer; Corey T Watson; Steven H Kleinstein; Daved H Fremont; Michael S Diamond; Ali H Ellebedy
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.426

9.  Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination.

Authors:  Yuxin Chen; Liguo Zhu; Weijin Huang; Xin Tong; Hai Wu; Yue Tao; Bei Tong; Haibin Huang; Jiachen Chen; Xiangan Zhao; Yang Lou; Chao Wu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

10.  Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.

Authors:  Rena D Astronomo; Maria P Lemos; Sandeep R Narpala; Julie Czartoski; Lamar Ballweber Fleming; Kelly E Seaton; Madhu Prabhakaran; Yunda Huang; Yiwen Lu; Katharine Westerberg; Lily Zhang; Mary K Gross; John Hural; Hong-Van Tieu; Lindsey R Baden; Scott Hammer; Ian Frank; Christina Ochsenbauer; Nicole Grunenberg; Julie E Ledgerwood; Kenneth Mayer; Georgia Tomaras; Adrian B McDermott; M Juliana McElrath
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.